As of 2026-03-12, the Relative Valuation of Eli Lilly and Co (LLY) is 452.65 USD. This relative valuation is based on P/E multiples. With the latest stock price at 995.76 USD, the upside of Eli Lilly and Co based on Relative Valuation is -54.5%.
The range of the Relative Valuation is 408.23 - 522.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.9x | 19.8x |
| Forward P/E multiples | 17.1x - 20.6x | 19.4x |
| Fair Price | 408.23 - 522.63 | 452.65 |
| Upside | -59.0% - -47.5% | -54.5% |
| Date | P/E |
| 2026-03-11 | 45.61 |
| 2026-03-10 | 45.87 |
| 2026-03-09 | 46.19 |
| 2026-03-06 | 45.36 |
| 2026-03-05 | 45.04 |
| 2026-03-04 | 45.97 |
| 2026-03-03 | 46.16 |
| 2026-03-02 | 46.63 |
| 2026-02-27 | 48.19 |
| 2026-02-26 | 46.82 |
| 2026-02-25 | 47.13 |
| 2026-02-24 | 47.74 |
| 2026-02-23 | 48.49 |
| 2026-02-20 | 46.24 |
| 2026-02-19 | 46.87 |
| 2026-02-18 | 46.75 |
| 2026-02-17 | 47.46 |
| 2026-02-13 | 47.64 |
| 2026-02-12 | 47.56 |
| 2026-02-11 | 46.50 |
| 2026-02-10 | 46.95 |
| 2026-02-09 | 47.85 |
| 2026-02-06 | 48.47 |
| 2026-02-05 | 46.76 |
| 2026-02-04 | 50.71 |
| 2026-02-03 | 45.97 |
| 2026-02-02 | 47.83 |
| 2026-01-30 | 47.51 |
| 2026-01-29 | 46.91 |
| 2026-01-28 | 46.90 |
| 2026-01-27 | 47.62 |
| 2026-01-26 | 48.68 |
| 2026-01-23 | 48.75 |
| 2026-01-22 | 49.81 |
| 2026-01-21 | 49.40 |
| 2026-01-20 | 47.70 |
| 2026-01-16 | 47.57 |
| 2026-01-15 | 47.32 |
| 2026-01-14 | 49.16 |
| 2026-01-13 | 49.34 |
| 2026-01-12 | 49.52 |
| 2026-01-09 | 48.72 |
| 2026-01-08 | 49.71 |
| 2026-01-07 | 50.76 |
| 2026-01-06 | 48.74 |
| 2026-01-05 | 47.71 |
| 2026-01-02 | 49.49 |
| 2025-12-31 | 49.23 |
| 2025-12-30 | 49.46 |
| 2025-12-29 | 49.41 |